CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for SpectraScience Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

SpectraScience Inc
11568 Sorrento Valley Road, Suite 11
Phone: (858) 847-0200p:858 847-0200 SAN DIEGO, CA  92121  United States Ticker: SCIESCIE

Business Summary
SpectraScience, Inc. is focused on developing its WavSTAT Optical Biopsy System (WavSTAT). The WavSTAT employs a risk technology that optically illuminates tissue in real-time to distinguish between normal and pre-cancerous or cancerous tissue. The Company has developed a technology platform to determine if tissue is normal, pre-cancerous or cancerous, without the need for a physical biopsy. The WavSTAT4 Optical Biopsy System operates by using cool, safe ultraviolet (UV) laser light to optically illuminate and analyze tissue, enabling the physician to make a diagnosis during endoscopy when screening for cancer and, if warranted, to begin immediate treatment during the same procedure. The WavSTAT4 uses laser-induced auto-fluorescence to obtain spectral information from tissue at the suspected site. The system is classified as a non-significant risk device, which transmits low-level UV laser light energy through an optical fiber to the tissue through the working channel of an endoscope.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201712/31/2016YesYes---

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board Mark D.McWilliams 62 11/29/2010 1/1/2004
President, Chief Executive Officer, Director Michael P.Oliver 68 9/30/2013 11/29/2010
Chief Financial Officer, Secretary Lowell W.Giffhorn 70 9/30/2013 9/30/2013
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Oncoscope, Inc. 324 Blackwell Street Durham NC United States

Business Names
Business Name
LUMA Imaging Corporation
Oncoscope, Inc.
SCIE
SpectraScience International, Inc.
SpectraScience, Inc.

General Information
Number of Employees: 5 (As of 12/31/2016)
Outstanding Shares: 4,823,923,779 (As of 11/2/2017)
Shareholders: 800
Stock Exchange: OTC
Federal Tax Id: 411448837
Fax Number: (858) 847-0880
Email Address: information@spectrascience.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, August 28, 2023